Home › Markets › Health Care › CING

Cingulate Inc. (CING)

CING trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$4.72
-2.48% on the day
Market cap
$68.6M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerCING on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2021
SEC CIK0001862150
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-04-28
Latest annual report10-K2026-03-18
Latest quarterly / interim10-Q2026-08-13
Latest current report8-K2026-10-02
Latest proxyDEF 14A2026-05-29

Source: SEC EDGAR submissions feed, 493 recent filings. All filings on EDGAR.

Other listings for this company

TickerNamePrice
CINGWCingulate Inc. Warrants$0.0050

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
NMADNomad Power Solutions Inc.$4.28+2.64%$68.9M
HYFTMindWalk Holdings Corp.$1.48+5.71%$69.7M
OSTXOS Therapies Incorporated$1.45-7.05%$67.4M
ZYBTZhengye Biotechnology Holding Limited$1.48-12.43%$70.1M
SPROSpero Therapeutics Inc.$1.15-2.54%$67.0M
XBITXBiotech Inc.$2.16-5.68%$65.9M
MAIAMAIA Biotechnology Inc.$1.16-1.70%$71.6M
RNTXRein Therapeutics Inc.$0.7546-3.86%$65.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier